Psoriasis News

There was a "night and day difference" in the results from bimekizumab compared against two established psoriasis drugs.

Chronic inflammation in people with psoriasis is associated with the development of plaque in heart arteries, which increases the risk of coronary artery disease. In biologic therapy, patients receive protein-based infusions to reduce inflammation.

The researchers found that among patients randomly assigned to use the cream once a day, roughly one-quarter saw their skin clear up within six weeks

Although two new studies suggest a link between mental health and psoriasis, neither paper can prove that one causes the other, only that the two are associated.

The use of inflammation-suppressing drugs known as biologics appeared to be linked with a slowed buildup of fatty plaques in arteries in a recent study.

The closer a person with psoriasis adhered to the Mediterranean diet, which emphasizes fruits, vegetables, grains, fish and healthy fats, the less onerous their psoriasis became, a new French study says.

An analysis of federal government health survey data from 2001 to 2013 found that black, Asian and other minorities are less likely than white people in the United States to see a doctor for treatment of the chronic inflammatory disease.

People with the skin disease psoriasis are at increased risk for type 2 diabetes, and the more severe the psoriasis, the greater their risk, a new study finds.

But experts say there may be ways to reduce those odds

Researchers say this may explain why more males seek treatment for the skin disease

But Siliq poses increased risk of suicidal behavior, agency warns

Quality-of-life boost seen in obese patients who lost significant amounts

This chronic skin disease can affect overall health, dermatologist says

Moderate-to-severe skin disease improved with Taltz over 60 weeks, study finds

A genetic link is one theory for the possible association, researchers say

But overall chances of experiencing often fatal ruptures remain small, doctors say

But experts say much more work lies ahead before people might benefit

Chronic skin disorder linked to increase risk for heart attack and stroke

But research doesn't prove one causes the other

Targeted therapies produce significant results, researchers say

Embarrassment, discomfort and concerns about drug side effects may play a role, experts say

Guselkumab appears more effective than standard treatment, researchers report

Ixekizumab appeared to outperform standard medication in a late-stage clinical trial

But experts say complication is rare, and no reason to stop medication

Cosentyx blocks protein involved in inflammatory response of disease